Document Detail

Vibroacoustic stimulation for fetal assessment in labour in the presence of a nonreassuring fetal heart rate trace.
MedLine Citation:
PMID:  23440793     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Fetal vibroacoustic stimulation (VAS) is a simple, non-invasive technique where a device is placed on the maternal abdomen over the region of the fetal head and sound is emitted at a predetermined level for several seconds. It is hypothesised that the resultant startle reflex in the fetus and subsequent fetal heart rate (FHR) acceleration or transient tachycardia following VAS provide reassurance of fetal well-being. This technique has been proposed as a tool to assess fetal well-being in the presence of a nonreassuring cardiotocographic (CTG) trace during the first and second stages of labour.
OBJECTIVES: To evaluate the clinical effectiveness and safety of VAS in the assessment of fetal well-being during labour, compared with mock or no stimulation for women with a singleton pregnancy exhibiting a nonreassuring FHR pattern.
SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (6 September 2012) and reference lists of all retrieved articles. We sought unpublished trials and abstracts submitted to major international congresses and contacted expert informants.
SELECTION CRITERIA: All published and unpublished randomised trials that compared maternal and fetal/neonatal/infant outcomes when VAS was used to evaluate fetal status in the presence of a nonreassuring CTG trace during labour, compared with mock or no stimulation.
DATA COLLECTION AND ANALYSIS: Two review authors independently sought to assess for inclusion all the potential studies we identified as a result of the search strategy. We planned to resolve any disagreement through discussion or, if required, to consult a third person. Where there was uncertainty about a particular study, we attempted to contact study authors for additional information. However, these attempts were unsuccessful.
MAIN RESULTS: The search strategies yielded six studies for consideration of inclusion. However, none of these studies fulfilled the requirements for inclusion in this review.
AUTHORS' CONCLUSIONS: There are currently no randomised controlled trials that address the safety and efficacy of VAS used to assess fetal well-being in labour in the presence of a nonreassuring CTG trace. Although VAS has been proposed as a simple, non-invasive tool for assessment of fetal well-being, there is insufficient evidence from randomised trials on which to base recommendations for use of VAS in the evaluation of fetal well-being in labour in the presence of a nonreassuring CTG trace.
Christine E East; Rebecca M D Smyth; Leo R Leader; Naomi E Henshall; Paul B Colditz; Rosalind Lau; Kelvin H Tan
Related Documents :
8375533 - Effects of selective reduction in triplet gestation: a comparative study of 80 cases ma...
20500973 - Monochorionic diamniotic triplet pregnancy with prenatal diagnosis of cord entanglement.
12468163 - The recurrence risk of adverse outcome in the second pregnancy in women with rheumatic ...
Publication Detail:
Type:  Journal Article; Review     Date:  2013-01-31
Journal Detail:
Title:  The Cochrane database of systematic reviews     Volume:  1     ISSN:  1469-493X     ISO Abbreviation:  Cochrane Database Syst Rev     Publication Date:  2013  
Date Detail:
Created Date:  2013-02-26     Completed Date:  2013-03-12     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  100909747     Medline TA:  Cochrane Database Syst Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  CD004664     Citation Subset:  IM    
School of Nursing and Midwifery/Maternity Services, Monash University/Southern Health, Clayton, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acoustic Stimulation / methods*
Fetal Monitoring / methods*
Heart Rate, Fetal / physiology
Startle Reaction / physiology
Update Of:
Cochrane Database Syst Rev. 2005;(2):CD004664   [PMID:  15846725 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Phytomedicines (medicines derived from plants) for sickle cell disease.
Next Document:  Screening for prostate cancer.